We. Grever et al., QUANTIFICATION OF MYELIN BASIC-PROTEIN IN THE HUMAN FETAL SPINAL-CORDDURING THE MIDTRIMESTER OF GESTATION, Journal of comparative neurology, 376(2), 1996, pp. 306-314
The amount of myelin basic protein (MBP) was quantified in human fetal
spinal cords from 12 to 24 gestational weeks (GW). MBP expression was
determined by Northern blot, quantitative immunoblot, and immunocytoc
hemistry. The development of compact myelin was analyzed by electron m
icroscopy. Thirty-eight human fetal spinal cords were obtained after e
lective termination of intrauterine pregnancies from healthy women. No
rthern blot analysis showed a 15.8-fold increase in MBP mRNA between 1
2 and 18 GW. From 18 to 24 GW, MBP mRNA Increased by 2.2-fold. The mRN
A data paralleled immunoblot results that showed a 90.5-fold increase
in MBP (0.147 ng/mg to 13.3 ng/mg tissue) between 12 and 18 GW and an
approximately 11.5-fold increase between 18 and 24 GW (13.3 ng/mg to 1
54 ng/mg tissue). Immunocytochemical analysis also showed increased st
aining for MBP with advancing gestational age. At 12 GW, MBP immunorea
ctivity was observed in all three spinal cord funiculi. By 18 GW, MBP
was expressed throughout the spinal cord white matter with the excepti
on of the lateral corticospinal tracts and in the rostral levels of th
e fasciculus gracilis. With respect to myelin, at 12 GW, rare, noncomp
acted myelin lamellae were observed by electron microscopy. By 18 GW,
discrete areas of compact myelin were observed in areas that showed MB
P immunoreactivity, and at 24 GW, compact myelin was prominent through
out the white matter of the spinal cord. This study demonstrates a qua
ntitative increase in MBP expression that is associated with myelin fo
rmation during the second trimester of human gestation. This informati
on may provide normative data that can aid in the diagnosis of myelin
disorders of the preterm, neonatal, and pediatric spinal cord. (C) 199
6 Wiley-Liss, Inc.